IOK Therapy for PTSD
(IOK Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new treatment for Veterans with PTSD, particularly those experiencing moral injury from involvement in wartime killing. The study compares a therapy called Impact of Killing (IOK), which targets moral injury, with a more general therapy addressing the overall impact of trauma. It seeks to determine if IOK can enhance daily life and reduce PTSD symptoms for Veterans, and if these improvements persist over time. Veterans who have experienced distress from actions in a war zone and have previously tried other PTSD treatments might be well-suited for this trial. As an unphased trial, it offers Veterans a unique opportunity to explore new therapeutic options tailored to their specific experiences.
Do I have to stop taking my current medications for the trial?
You don't have to stop taking your current medications, but you must be stable on your PTSD medication for one month and not change it during the study.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that the Impact of Killing (IOK) treatment is generally well-tolerated by participants. In a previous study, individuals who received IOK experienced significant improvements in PTSD symptoms and overall mental health. These studies reported no major safety concerns, and most participants completed the treatment. Only two individuals, one from each group, did not finish the treatment. This suggests that the treatment is manageable for most participants. Overall, IOK appears to be a safe option for those dealing with PTSD related to moral injury.12345
Why are researchers excited about this trial?
Unlike standard PTSD treatments that often focus on trauma exposure or cognitive restructuring, the Impact of Killing (IOK) therapy takes a unique approach by specifically addressing moral injury. This treatment is designed for individuals dealing with the emotional and psychological impact of having killed in a combat situation, which is not typically the focus of traditional PTSD therapies like Cognitive Processing Therapy or Prolonged Exposure Therapy. Researchers are excited about IOK because it aims to help participants process and heal from the moral and ethical dilemmas they faced, potentially offering relief to a group that might not fully benefit from existing treatments. By targeting the moral injury aspect, IOK could provide a more tailored and effective treatment option for veterans and others with similar experiences.
What evidence suggests that this trial's treatments could be effective for PTSD?
Research has shown that Impact of Killing (IOK) therapy, one of the treatments in this trial, can significantly reduce PTSD symptoms. In one study, participants who received IOK therapy experienced fewer PTSD symptoms and other mental health issues compared to those who did not. They also reported an improved quality of life after treatment. IOK therapy addresses moral injury, which arises when actions during war, such as killing, conflict with personal beliefs. This approach has shown promise in helping Veterans manage their experiences and enhance their daily lives. Meanwhile, another group in this trial will receive Present Centered Therapy (PCT), which focuses on the functional impact of trauma without emphasizing trauma or cognitive restructuring.12367
Who Is on the Research Team?
Shira Maguen, PhD
Principal Investigator
San Francisco VA Medical Center, San Francisco, CA
Are You a Good Fit for This Trial?
This trial is for Veterans aged 18-82 with PTSD related to moral injury from killing in war. They must have completed or be stable on PTSD treatments like CPT or PE, and not changing medications during the study. Those with recent severe mental health issues, substance dependence, or active suicidal behaviors cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either Impact of Killing (IOK) or Present Centered Therapy (PCT) for 10 sessions, each lasting 60-90 minutes
Follow-up
Participants are monitored for psychosocial functioning and PTSD severity, with assessments at 6 months post-treatment
What Are the Treatments Tested in This Trial?
Interventions
- Impact of Killing (IOK)
- Present Centered Therapy
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor